SEC Tracker
Get the app

Azora Therapeutics, Inc. (DE) AZR

Azora Therapeutics, Inc. reports ownership change.

Coastlands Capital LP, insider filing for AZR

Form
4
Filed
Importance
Routine
  1. Coastlands Capital LP owned 388,308 common shares.
  2. Series A Preferred Stock converted to common stock on Nov 2, 2026.
  3. Reporting persons no longer own more than 10% of common stock.

Written from the Form 4 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Azora Therapeutics, Inc. (DE) files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. AIM ImmunoTech AIM public float $6M, Jun 30, 2025
  2. Vyome Holdings HIND public float $6M, Jun 30, 2025
  3. Biomerica BMRA public float $7M, Nov 28, 2025
  4. Protagenic Therapeutics, Inc.\new PTIX public float $7M, Sep 30, 2025
  5. PharmaCyte Biotech PMCB public float $6M, Oct 31, 2025